Written by A recent collaborative research endeavor, published in Cell Reports Medicine, highlights a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS). Led by researchers from Ben-Gurion University of the Negev in conjunction with counterparts from Germany, the U.S., and Canada, the study delves into the potential of augmenting macrophage migration inhibitory factor (MIF) protein levels as a novel approach to tackling ALS.
Medical Xpress – latest medical and health news stories